Avadel Pharmaceuticals plc

NasdaqGM:AVDL Stock Report

Market Cap: US$1.7b

Avadel Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of AVDL?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders00%
Private Companies420.0000464%
Institutions12,260,25113.5%
General Public78,316,70586.5%

Dilution of Shares: AVDL only recently listed within the past 12 months


Top Shareholders

Top 7 shareholders own 13.54% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.3%
Janus Henderson Group plc
11,125,330US$209.4m-50%0.09%
0.73%
SEB Investment Management AB
658,660US$12.4m5.14%0.02%
0.47%
DWS Investment Management Americas, Inc.
425,000US$8.0m41.7%0.04%
0.038%
Penn Capital Management Company, LLC
34,034US$640.4k0%0.05%
0.012%
Medical Strategy GmbH, Asset Management Arm
11,300US$212.7k0%0.01%
0.0065%
Invesco Capital Management LLC
5,927US$111.5k34.8%no data
0.00005%
Avior Wealth Management, LLC
42US$852.30%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.